|
C15ORF29 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.376400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.418800E-01 |
| Normal-vs-Stage2 |
5.478400E-01 |
| Normal-vs-Stage3 |
4.221600E-01 |
| Normal-vs-Stage4 |
4.906800E-01 |
| Stage1-vs-Stage2 |
4.321600E-01 |
| Stage1-vs-Stage3 |
3.884200E-01 |
| Stage1-vs-Stage4 |
5.128000E-01 |
| Stage2-vs-Stage3 |
2.394800E-01 |
| Stage2-vs-Stage4 |
2.793000E-01 |
| Stage3-vs-Stage4 |
9.240400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.313000E-01 |
| Normal-vs-AfricanAmerican |
9.778400E-01 |
| Normal-vs-Asian |
1.448380E-01 |
| Caucasian-vs-AfricanAmerican |
6.441000E-01 |
| Caucasian-vs-Asian |
1.334990E-01 |
| AfricanAmerican-vs-Asian |
1.450210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.725600E-01 |
| Normal-vs-Female |
4.715400E-01 |
| Male-vs-Female |
2.088300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.606200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.800200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.728400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.810000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.626000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.055600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.322400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.171040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.101800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.992600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.076000E-01 |
| Normal-vs-Grade 2 |
4.746000E-01 |
| Normal-vs-Grade 3 |
1.508570E-01 |
| Normal-vs-Grade 4 |
1.443990E-01 |
| Grade 1-vs-Grade 2 |
4.826600E-01 |
| Grade 1-vs-Grade 3 |
3.094400E-02 |
| Grade 1-vs-Grade 4 |
4.078300E-02 |
| Grade 2-vs-Grade 3 |
8.064800E-03 |
| Grade 2-vs-Grade 4 |
1.862480E-02 |
| Grade 3-vs-Grade 4 |
6.416400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.264200E-01 |
| Normal-vs-ccB subtype |
7.239800E-01 |
| ccA subtype-vs-ccB subtype |
3.070200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.098400E-01 |
| Normal-vs-N1 |
3.625400E-01 |
| N0-vs-N1 |
3.504800E-01 |
|
|
